Germitec SA

Germitec is an innovative French MedTech company specializing in High-Level Disinfection (HLD) using ultraviolet-C (UV-C) technology for ultrasound probes and non-channeled endoscopes. Its patented Yuvee® technology removes the need for chemical disinfectants, reducing healthcare workers’ exposure while streamlining clinical workflows. It improves probes turnaround and ensures automated traceability of each disinfection cycle. Clinically validated and compliant with European and international standards, Germitec’s systems strengthen infection prevention and enhance patient safety. The company is committed to delivering safe, efficient, and sustainable solutions that support high hygiene standards.
PFE is the official distributor of Germitec products for the UK.

Approach to Healthcare

Germitec’s approach to healthcare is driven by patient safety, operational efficiency, and environmental responsibility. The company focuses on preventing infection risks through UV-C disinfection technologies that eliminate the use of chemicals. Germitec simplifies complex reprocessing workflows. Its solutions are designed to reduce human error, improve compliance with hygiene standards, and ensure consistent HLD. Germitec’s goal is to support safer care while optimizing daily medical practices.

Impact on Healthcare

Germitec’s products have a strong impact on healthcare by significantly improving infection prevention practices. Its technology enables faster and more efficient reprocessing of ultrasound probes and non-channeled endoscopes. It enhances staff safety and reduces environmental impact. In addition, automated traceability supports regulatory compliance. Overall, Germitec’s solutions help reduce operational constraints while offering a more sustainable and cost-effective approach.

Innovation

Germitec transforms HLD for ultrasound probes and non-channeled endoscopes across clinical settings using UV-C. Chronos® delivers HLD in 90 seconds for gynecology, urology, emergency, and radiology, while Chronos® Max achieves HLD in 4 minutes for ENT and cardiology. These systems replace complex chemical workflows with a fast, simple point-of-care solution, setting a new standard in infection prevention.

Future Direction

Germitec aims to broaden the adoption of its UV-C disinfection solutions across healthcare settings. The company will continue to innovate by enhancing its technologies, improving compatibility, and expanding product applications beyond current indications. Its ambition is to play a key role in shaping the future of infection prevention in healthcare.